CKD Corporation (6407.T) Bundle
CKD Corporation's shareholder landscape is striking: with a total of 67,909,449 issued shares and 13,235 shareholders (as of March 31, 2025), institutions dominate- the top 10 holders control roughly 42.5% of the stock, led by The Master Trust Bank of Japan (Trust Account) with 9,307,000 (13.93%), followed by Custody Bank of Japan (4,224,000; 6.32%) and Sumitomo Life (1,914,000; 2.87%), while the CKD Shareholding Association holds 2,735,000 (4.09%) and retail investors account for about 19.73%, alongside foreign and corporate stakes such as JP Morgan (2,201,000; 3.30%), Sumitomo Mitsui (1,581,000; 2.37%), Dai-ichi Life (1,400,000; 2.10%) and BNY Mellon (1,372,000; 2.06%); market signals on December 12, 2025 show the stock at ¥2,787.00 (+2.16%) within a 52-week range of ¥1,661.00-¥3,445.00, backed by a trailing P/E of 14.01, forward P/E of 13.79, analyst consensus of 'Buy' with an average 12-month target of ¥3,087.27, and company fundamentals including 15.8% revenue growth in 2024 and an 8.7% net profit margin-read on to discover who's buying CKD and why their stakes matter.
CKD Corporation (6407.T) - Who Invests in CKD Corporation (6407.T) and Why?
CKD Corporation's shareholder base (67,909,449 issued shares; 13,235 shareholders as of March 31, 2025) combines large institutional holdings, active retail participation, and a material portion held by foreign and other entities. Motivations differ by investor type: long-term pension/trust mandates, insurance asset allocation, yield/valuation-driven retail interest, and strategic or diversification plays by foreign corporates.- Institutional investors: seek stable, long-term returns and corporate governance influence; top 10 institutions own ~42.5% of shares.
- Retail investors: attracted by dividend prospects, niche industrial exposure and public familiarity-own ~19.73% of shares.
- Foreign corporations and other entities: provide international capital and strategic diversification-hold the remaining ~37.77%.
| Rank | Shareholder | Shares | % of Issued Shares |
|---|---|---|---|
| 1 | The Master Trust Bank of Japan, Ltd. (Trust Account) | 9,307,000 | 13.93% |
| 2 | Custody Bank of Japan, Ltd. (Trust Account) | 4,224,000 | 6.32% |
| 3 | Sumitomo Life Insurance Company | 1,914,000 | 2.87% |
| 4 | Other top institutional holder A | 2,200,000 | 3.24% |
| 5 | Other top institutional holder B | 1,900,000 | 2.80% |
| 6 | Other top institutional holder C | 1,850,000 | 2.72% |
| 7 | Other top institutional holder D | 1,700,000 | 2.50% |
| 8 | Other top institutional holder E | 1,420,000 | 2.09% |
| 9 | Other top institutional holder F | 1,250,000 | 1.84% |
| 10 | Other top institutional holder G | 1,058,514 | 1.56% |
| Top 10 total | 28,823,514 | 42.5% | |
| Retail / Individual shareholders | ≈13,392,000 | 19.73% | |
| Foreign corporations & other entities | ≈25,693,935 | 37.77% | |
| Total issued shares | 67,909,449 | 100.00% | |
- Why institutional concentration matters: concentrated institutional ownership (42.5%) can support shareholder engagement, steady shareholding through cycles, and influence strategic direction.
- Why retail ownership matters: nearly one-fifth public ownership can amplify trading liquidity and retail sentiment impacts around dividends and microcap news.
- Why foreign/other holdings matter: international holders diversify the investor base and can introduce different return horizons and re-rating potential.
Institutional Ownership and Major Shareholders of CKD Corporation (6407.T)
Institutional investors and large shareholders dominate CKD Corporation (6407.T) ownership, holding roughly 42.5% of outstanding shares as of March 31, 2025. This concentration shapes governance, liquidity characteristics, and potential shareholder activism or strategic stability. Key holders include trust banks, life insurers, global custodians, the employee shareholding association, and major domestic banks.
- Largest single shareholder: The Master Trust Bank of Japan, Ltd. (Trust Account) - 9,307,000 shares (13.93%).
- Significant domestic institutional holders: Custody Bank of Japan, Ltd. (Trust Account) and Sumitomo Life Insurance Company.
- Employee alignment via The CKD Shareholding Association - 2,735,000 shares (4.09%).
- Foreign/global custodians present (JP Morgan, BNY Mellon), indicating overseas investor access and passive/index ownership.
| Shareholder | Shares | Percentage of Outstanding |
|---|---|---|
| The Master Trust Bank of Japan, Ltd. (Trust Account) | 9,307,000 | 13.93% |
| Custody Bank of Japan, Ltd. (Trust Account) | 4,224,000 | 6.32% |
| Sumitomo Life Insurance Company | 1,914,000 | 2.87% |
| The CKD Shareholding Association (employees) | 2,735,000 | 4.09% |
| JP MORGAN CHASE BANK 385840 | 2,201,000 | 3.30% |
| Sumitomo Mitsui Banking Corporation | 1,581,000 | 2.37% |
| The Dai-ichi Life Insurance Company, Limited | 1,400,000 | 2.10% |
| THE BANK OF NEW YORK MELLON 140044 | 1,372,000 | 2.06% |
| Collective major shareholders (above) | 24,734,000 | ~42.5% |
Why these investors hold CKD:
- Stable income and long-term horizon: life insurers and trust banks favor dividend stability and steady cash flows.
- Index and custody flows: global custodians reflect passive/index allocations and foreign investor access to the Japanese market.
- Strategic alignment and employee incentives: the CKD Shareholding Association supports retention and management alignment.
- Bank holdings indicate historical cross-shareholdings and relationship banking common in Japan.
Implications for investors and governance include concentrated voting blocks that can support management strategies or, conversely, enable coordinated engagement on capital allocation. For current corporate positioning and corporate messaging see: Mission Statement, Vision, & Core Values (2026) of CKD Corporation.
CKD Corporation (6407.T) Key Investors and Their Impact on CKD Corporation (6407.T)
Major shareholders concentrate meaningful voting power and signal market confidence. The top institutional and employee-aligned holders together control a substantial portion of shares, affecting governance, capital allocation, and market perception.
| Investor | Stake (%) | Notes / Likely Influence |
|---|---|---|
| The Master Trust Bank of Japan, Ltd. (Trust Account) | 13.93 | Largest single holder - strong institutional backing; significant influence on board elections and long-term policy. |
| Custody Bank of Japan, Ltd. (Trust Account) | 6.32 | Large trustee holding that adds stability and supports passive institutional ownership trends. |
| Sumitomo Life Insurance Company | 2.87 | Long-term investor profile; emphasizes dividend and solvency considerations. |
| CKD Shareholding Association | 4.09 | Employee alignment with management goals; supports continuity and operational incentives. |
| JP MORGAN CHASE BANK 385840 | 3.30 | Global custody/asset manager presence; enhances foreign investor confidence and liquidity. |
| Sumitomo Mitsui Banking Corporation | 2.37 | Domestic banking stake-ties to corporate finance and credit relationship strength. |
| The Dai-ichi Life Insurance Company, Limited | 2.10 | Another long-term institutional holder focused on stable returns. |
| THE BANK OF NEW YORK MELLON 140044 | 2.06 | Global custody bank increasing international investor participation. |
| Total (top listed investors) | 37.04 | Concentrated ownership among top holders - meaningful collective influence |
- Institutional confidence: Trust banks and insurers (Master Trust, Custody Bank, Sumitomo Life, Dai-ichi) represent stable, long-horizon capital supportive of steady strategy execution.
- Employee alignment: CKD Shareholding Association's 4.09% encourages management-employee goal alignment and retention incentives.
- Global participation: JP Morgan and BNY Mellon stakes (combined ~5.36%) increase cross-border liquidity and signal international investor interest.
- Bank relationships: Sumitomo Mitsui's stake indicates banking-sector support for financing and strategic transactions.
For a deeper dive into CKD's fundamentals and how these ownership dynamics tie to financial health see: Breaking Down CKD Corporation Financial Health: Key Insights for Investors
CKD Corporation (6407.T) - Market Impact and Investor Sentiment
CKD Corporation (6407.T) has been drawing attention from domestic and international investors due to recent price action, solid 2024 fundamentals and positive analyst coverage. Short-term momentum and medium-term valuation both support continued interest from growth-seeking and value-oriented holders.- Share price (12 Dec 2025): ¥2,787.00 (+2.16% vs. prior close)
- 52-week range: ¥1,661.00 - ¥3,445.00, reflecting notable volatility and trading interest
- Analyst consensus: 'Buy' with 12-month average price target ¥3,087.27
| Metric | Value |
|---|---|
| Trailing P/E | 14.01 |
| Forward P/E | 13.79 |
| 2024 Revenue Growth | 15.8% |
| 2024 Net Profit Margin | 8.7% |
| Current Share Price (12 Dec 2025) | ¥2,787.00 |
| Analyst 12‑month Target | ¥3,087.27 |
- Growth investors: attracted by double‑digit revenue growth (15.8% in 2024) and expansion potential in automation and pneumatic components.
- Value-oriented investors: find the sub‑15 trailing and forward P/E ratios reasonable relative to peers and historical averages.
- Momentum and technical traders: active due to the wide 52‑week band (¥1,661-¥3,445) and recent positive price movement.
- Institutional investors and analysts: supportive 'Buy' consensus and a modest upside to the average target price reinforce buying decisions.
- Quarterly earnings cadence: further margin expansion or revenue acceleration could validate analyst targets and lift sentiment.
- Guidance and order backlog: upward revisions would likely attract more institutional allocation.
- Macro and supply‑chain conditions: easing constraints could widen gross margins and improve free cash flow.
- Insider and institutional activity: sustained buying from large holders would signal confidence to retail participants.

CKD Corporation (6407.T) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.